Company Filing History:
Years Active: 2008-2010
Title: André Pillez: Innovator in Hepatitis C Research
Introduction
André Pillez is a notable inventor based in Lille, France. He has made significant contributions to the field of virology, particularly in the study of the hepatitis C virus (HCV). With a total of 2 patents, his work focuses on innovative methods for understanding and replicating this virus.
Latest Patents
Pillez's latest patents include groundbreaking inventions related to nucleotide sequences coding for the non-structural proteins of the hepatitis C virus. The first patent concerns the use of cells capable of carrying out a process of prenylation of proteins coded by the HCV genome. This includes the prenylation of the NS5A protein, which is essential for replicating and producing HCV or its viable mutants in a suitable culture medium. The second patent also addresses a method for replicating the hepatitis C virus using similar cellular processes.
Career Highlights
André Pillez is affiliated with the Centre National de la Recherche Scientifique, a prestigious research institution in France. His work has been instrumental in advancing the understanding of hepatitis C and developing potential therapeutic strategies.
Collaborations
Pillez has collaborated with notable colleagues in his field, including Czeslaw Wychowski and Gilles Duverlie. Their combined expertise has contributed to the success of their research endeavors.
Conclusion
André Pillez's innovative work in hepatitis C research highlights the importance of scientific collaboration and the pursuit of knowledge in combating viral diseases. His contributions continue to pave the way for future advancements in virology.